{
    "nctId": "NCT04117815",
    "briefTitle": "Hair-Safe Study: Scalp Cooling for Hair Saving in Women Undergoing Chemotherapy",
    "officialTitle": "Hair-Safe Study: Scalp Cooling for Hair Saving in Women Undergoing Chemotherapy",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer Female, Alopecia",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 128,
    "primaryOutcomeMeasure": "Extent of hair preservation",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients with breast or gynecological cancer planning to undergo CT\n* CT can be neoadjuvant, adjuvant or palliative\n* Up to two lines of CT are allowed. Adjuvant therapy counts as one line\n* CT regime is associated with alopecia\n* CT must be planned for at least 4 cycles of taxane or anthracyline-based CT regimen\n* written informed consent age 18 and older\n\nExclusion Criteria:\n\n* Migraine\n* Cold allergy/Cold Agglutinins/Morbus Raynaud\n* Hematological malignancies (Leukemia, non Hodgkins and other generalized lymphomas)\n* Manifest scalp metastases\n* Overt cognitive impairment\n* Insufficient knowledge of German language\n\nReference Population:\n\n* Patients with breast or gynecological cancer planning to undergo CT\n* CT can be adjuvant, neoadjuvant or palliative\n* up to two lines of CT are allowed. Adjuvant therapy counts as one line.\n* CT regime is associated with alopecia\n* CT must be planned for at least 4 cycles of taxane or anthracycline-based CT regime\n* Refuse to undergo scalp cooling\n* Patients who have been excluded for the study group for the reason of migraine\n* written informed consent\n* age 18 and older",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}